Literature DB >> 20631877

The role of B cells in transplantation and immunopathic diseases.

A Basten1.   

Abstract

B cells, by virtue of their diverse roles in immune responses to foreign and self antigens, have become of increasing interest to the clinician as well as the basic immunologist. In particular, it is now apparent that the development of B cell unresponsiveness in antibody and T cell mediated autoimmune disorders and the transplant setting is both worthwhile and achievable.

Entities:  

Keywords:  B cells; Immunopathic diseases; Transplantation

Year:  2010        PMID： 20631877      PMCID： PMC2902673          DOI： 10.4110/in.2010.10.3.81

Source DB:  PubMed          Journal:  Immune Netw        ISSN： 1598-2629            Impact factor:   6.303


  35 in total

Review 1.  B cells move to centre stage: novel opportunities for autoimmune disease treatment.

Authors:  Jeffrey L Browning
Journal:  Nat Rev Drug Discov       Date:  2006-07       Impact factor: 84.694

2.  A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.

Authors:  V Zarkhin; L Li; N Kambham; T Sigdel; O Salvatierra; M M Sarwal
Journal:  Am J Transplant       Date:  2008-09-18       Impact factor: 8.086

3.  Regulatory T cell depletion enhances tumor specific CD8 T-cell responses, elicited by tumor antigen NY-ESO-1b in hepatocellular carcinoma patients, in vitro.

Authors:  Heng-Hui Zhang; Ming-Hui Mei; Ran Fei; Wei-Jia Liao; Xue-Yan Wang; Li-Ling Qin; Jiang-Hua Wang; Lai Wei; Hong-Song Chen
Journal:  Int J Oncol       Date:  2010-04       Impact factor: 5.650

4.  Donor-specific B-cell tolerance after ABO-incompatible infant heart transplantation.

Authors:  Xiaohu Fan; Andrew Ang; Stacey M Pollock-Barziv; Anne I Dipchand; Phillip Ruiz; Gregory Wilson; Jeffrey L Platt; Lori J West
Journal:  Nat Med       Date:  2004-10-24       Impact factor: 53.440

Review 5.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

6.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Authors:  Jonathan C W Edwards; Leszek Szczepanski; Jacek Szechinski; Anna Filipowicz-Sosnowska; Paul Emery; David R Close; Randall M Stevens; Tim Shaw
Journal:  N Engl J Med       Date:  2004-06-17       Impact factor: 91.245

7.  Regulatory role of B cells in a murine model of allergic airway disease.

Authors:  Anurag Singh; William F Carson; Eric R Secor; Linda A Guernsey; Richard A Flavell; Robert B Clark; Roger S Thrall; Craig M Schramm
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

8.  CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients.

Authors:  Paul A Blair; Lina Yassin Noreña; Fabian Flores-Borja; David J Rawlings; David A Isenberg; Michael R Ehrenstein; Claudia Mauri
Journal:  Immunity       Date:  2010-01-14       Impact factor: 31.745

Review 9.  Rituximab: beyond simple B cell depletion.

Authors:  A Kessel; I Rosner; E Toubi
Journal:  Clin Rev Allergy Immunol       Date:  2008-02       Impact factor: 8.667

10.  Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial.

Authors:  Clifton O Bingham; R John Looney; Atul Deodhar; Neal Halsey; Maria Greenwald; Christine Codding; Benjamin Trzaskoma; Flavius Martin; Sunil Agarwal; Ariella Kelman
Journal:  Arthritis Rheum       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.